scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1462-5822.2006.00758.X |
P698 | PubMed publication ID | 16848789 |
P2093 | author name string | Robert Lodge | |
Albert Descoteaux | |||
Tamsir O. Diallo | |||
P2860 | cites work | Leishmania donovani promastigotes induce periphagosomal F-actin accumulation through retention of the GTPase Cdc42. | Q40365192 |
Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages | Q40385901 | ||
Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana | Q40387461 | ||
The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly | Q40591985 | ||
Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes | Q40816233 | ||
Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes. | Q40826573 | ||
Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages | Q40849883 | ||
Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan | Q41104354 | ||
Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages | Q42935488 | ||
Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. | Q43582908 | ||
Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi | Q43664759 | ||
A novel assay system implicates PtdIns(3,4)P(2), PtdIns(3)P, and PKC delta in intracellular production of reactive oxygen species by the NADPH oxidase | Q44283104 | ||
Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils | Q44560490 | ||
Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release | Q45304896 | ||
Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria. | Q46763949 | ||
A specialized pathway affecting virulence glycoconjugates of Leishmania | Q48070473 | ||
Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. | Q50122203 | ||
Leishmania major: respiratory burst response of infected murine macrophages treated with paromomycin. | Q50782183 | ||
Purification and Structural Characterization of a Filamentous, Mucin-like Proteophosphoglycan Secreted byLeishmaniaParasites | Q58039511 | ||
Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis | Q31869128 | ||
Glycoconjugates in Leishmania infectivity | Q33778464 | ||
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals | Q33848491 | ||
Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation | Q34007906 | ||
NADPH oxidase | Q34064135 | ||
Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species | Q34232557 | ||
Assembly of the phagocyte NADPH oxidase | Q34338562 | ||
Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages | Q34474594 | ||
The neutrophil NADPH oxidase | Q34497891 | ||
A phagosome of one's own: a microbial guide to life in the macrophage | Q34521808 | ||
Current molecular models for NADPH oxidase regulation by Rac GTPase | Q34915029 | ||
Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system | Q35178637 | ||
Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. | Q35202576 | ||
The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts | Q35234866 | ||
The role of phosphoinositides and phosphorylation in regulation of NADPH oxidase | Q35974253 | ||
Increased superoxide anion production by immunologically activated and chemically elicited macrophages | Q36341599 | ||
Golgi-mediated post-translational processing of secretory acid phosphatase by Leishmania donovani promastigotes | Q38341669 | ||
P433 | issue | 12 | |
P921 | main subject | Leishmania donovani | Q1950752 |
P304 | page(s) | 1922-1931 | |
P577 | publication date | 2006-12-01 | |
P1433 | published in | Cellular Microbiology | Q1921948 |
P1476 | title | Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane | |
P478 | volume | 8 |
Q47844218 | A proteogenomic approach to map the proteome of an unsequenced pathogen - Leishmania donovani |
Q34142338 | An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis |
Q92720638 | Anopheles stephensi Dual Oxidase Silencing Activates the Thioester-Containing Protein 1 Pathway to Suppress Plasmodium Development |
Q50124215 | Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight. |
Q49866040 | Cholesterol-lowering drug, in combination with chromium chloride, induces early apoptotic signals in intracellular L. donovani amastigotes, leading to death. |
Q101237461 | DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis |
Q34369161 | Deception and manipulation: the arms of leishmania, a successful parasite |
Q47556585 | Eat Prey, Live: Dictyostelium discoideum As a Model for Cell-Autonomous Defenses. |
Q37107579 | Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications |
Q34186778 | Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes |
Q34184759 | Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure |
Q35903321 | Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection |
Q39113003 | Host cell signalling and leishmania mechanisms of evasion. |
Q38699575 | Hydrophilic Acylated Surface Protein A (HASPA) of Leishmania donovani: Expression, Purification and Biophysico-Chemical Characterization |
Q38114928 | Imaging host-Leishmania interactions: significance in visceral leishmaniasis |
Q36915063 | Immune response regulation by leishmania secreted and nonsecreted antigens |
Q56927415 | Impact of Leishmania donovani infection on the HLA I self peptide repertoire of human macrophages |
Q36778997 | Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection |
Q92706755 | Infection and Activation of Human Neutrophils with Fluorescent Leishmania infantum |
Q37246574 | Inhibition of the human neutrophil NADPH oxidase by Coxiella burnetii |
Q38004492 | Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan. |
Q34675951 | Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity |
Q36971309 | Invasion and intracellular survival by protozoan parasites |
Q38843674 | Iron acquisition in Leishmania and its crucial role in infection |
Q55043523 | Leishmania Hijacks Myeloid Cells for Immune Escape. |
Q33742497 | Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy. |
Q33916025 | Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence |
Q41790297 | Leishmania amazonensis fails to induce the release of reactive oxygen intermediates by CBA macrophages. |
Q38322760 | Leishmania and the macrophage: a multifaceted interaction |
Q90292875 | Leishmania braziliensis: Strain-Specific Modulation of Phagosome Maturation |
Q38541158 | Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates |
Q91904124 | Leishmania donovani Lipophosphoglycan Increases Macrophage-Dependent Chemotaxis of CXCR6-Expressing Cells via CXCL16 Induction |
Q34119501 | Leishmania donovani amastigotes impair gamma interferon-induced STAT1alpha nuclear translocation by blocking the interaction between STAT1alpha and importin-alpha5 |
Q37288178 | Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts |
Q39055055 | Leishmania donovani prevents oxidative burst-mediated apoptosis of host macrophages through selective induction of suppressors of cytokine signaling (SOCS) proteins |
Q38640144 | Leishmania hijacking of the macrophage intracellular compartments |
Q55238577 | Leishmania infantum Lipophosphoglycan-Deficient Mutants: A Tool to Study Host Cell-Parasite Interplay. |
Q36046712 | Leishmania major Promastigotes Evade LC3-Associated Phagocytosis through the Action of GP63. |
Q21131305 | Leishmania promastigotes: building a safe niche within macrophages |
Q37152350 | Macrophage NADPH oxidase flavocytochrome B localizes to the plasma membrane and Rab11-positive recycling endosomes |
Q37118101 | Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. |
Q27010243 | Mechanisms of cellular invasion by intracellular parasites |
Q42643442 | Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages. |
Q34281699 | Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis. |
Q34845583 | Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity |
Q37218225 | Neisseria gonorrhoeae suppresses the oxidative burst of human polymorphonuclear leukocytes |
Q26751878 | One Health Approach Prospect for Integrated Control and Elimination of Visceral Leishmaniasis in Ethiopia: A Narrative Review Article |
Q39091538 | Peripheral blood fibrocytes: new information to explain the dynamics of Leishmania infection. |
Q27025454 | Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens |
Q45947334 | Protein disulfide isomerase (PDI) associates with NADPH oxidase and is required for phagocytosis of Leishmania chagasi promastigotes by macrophages. |
Q39435029 | Redundant and regulatory roles for Toll-like receptors in Leishmania infection. |
Q37183118 | Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins |
Q39317576 | Role of oxidative stress and apoptosis in the cellular response of murine macrophages upon Leishmania infection |
Q34251158 | Selective Fusion of Azurophilic Granules with Leishmania-containing Phagosomes in Human Neutrophils |
Q33892668 | Stage-specific pathways of Leishmania infantum chagasi entry and phagosome maturation in macrophages. |
Q33825619 | T3SS effector VopL inhibits the host ROS response, promoting the intracellular survival of Vibrio parahaemolyticus |
Q90206046 | The Leishmania Parasitophorous Vacuole Membrane at the Parasite-Host Interface |
Q33510916 | The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. |
Q39453649 | The Type VI secretion system of Burkholderia cenocepacia affects multiple Rho family GTPases disrupting the actin cytoskeleton and the assembly of NADPH oxidase complex in macrophages. |
Q38517526 | The genetics of Leishmania virulence |
Q92251994 | The host cell secretory pathway mediates the export of Leishmania virulence factors out of the parasitophorous vacuole |
Q37160811 | The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes |
Q98156819 | The macrophage microtubule network acts as a key cellular controller of the intracellular fate of Leishmania infantum |
Q37783925 | The many roles of NOX2 NADPH oxidase-derived ROS in immunity |
Q33565446 | The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis |
Q37405618 | Tracing immunity to human leishmaniasis |
Q37081691 | Transgenic Leishmania and the immune response to infection |
Q38012112 | Vaccine Development Against Leishmania donovani |
Q34076804 | Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches |
Q29038941 | Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? |
Search more.